Skip to main content

stock

GRCE · Grace Therapeutics, Inc.

What Grace Therapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live GRCE price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on GRCE.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
21,035,930 as of 2026-08-11 (XBRL frame )

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-41.9%
ROA
-40.4%

Health

Current ratio
11.5x
Debt/equity
—

Deep value

NCAV
$12.47M
NCAV per share
$0.59
Price/NCAV
Locked
NNWC
$11.89M
NNWC per share
$0.57
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$15.92M-$15.79M
10-Q filed 2026-08-13
2026-03-31——Gross profit: unreported by this company.-$3.01M-$1.18M
DEF 14A filed 2026-07-28
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31——Gross profit: unreported by this company.-$2.45M-$2.31M
10-Q filed 2026-02-12
2025-09-30——Gross profit: unreported by this company.-$2.53M-$938,000
10-Q filed 2026-02-12
Assembled from more than one filing; the filing above is only the newest of them.
2025-06-30——Gross profit: unreported by this company.-$3.09M-$3.36M
10-Q filed 2026-08-13
2025-03-31——Gross profit: unreported by this company.-$3.18M$636,000
DEF 14A filed 2026-07-28
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31——Gross profit: unreported by this company.-$3.70M-$4.16M
10-Q filed 2026-02-12
2024-09-30——Gross profit: unreported by this company.-$4.83M-$3.43M
10-Q filed 2026-02-12
Assembled from more than one filing; the filing above is only the newest of them.
Assets
$50.07M
Equity
$48.21M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2026-03-31—-$11.08M-$7.79M—
2025-03-31—-$16.68M-$9.57M—
2024-03-31—-$12.85M-$12.85M—
2023-03-31—-$52.16M-$42.43M—
2022-03-31$0-$15.59M-$9.82M—
2021-03-31$196,000-$16.42M-$19.68M—
2020-03-31—-$24.44M-$25.51M—
2019-03-31—-$34.41M-$39.37M—

Company filings

since Mon Aug 24

events

  • Shareholder vote results

    Shareholder vote results
    Sep 188-K
  • Results

    Results
    Aug 138-K
  • Material agreement, Unregistered share sale, Other event

    Material agreementUnregistered share saleOther event
    Aug 68-K
  • Other event

    Other event
    Jul 288-K
  • Other event

    Other event
    Jun 188-K
  • Results

    Results
    Jun 188-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Opaleye Management Inc.

    10% owner

    Buy$123,819

    Oct 5, 6:46 PM ET

  • Opaleye Management Inc.

    10% owner

    Buy$16,404

    Oct 1, 4:30 PM ET

  • Opaleye Management Inc.

    10% owner

    Buy$31,687

    Oct 1, 4:05 PM ET

  • Opaleye Management Inc.

    10% owner

    Buy$31,687

    Sep 23, 6:19 PM ET

  • Opaleye Management Inc.

    10% owner

    Buy$31,896

    Sep 10, 4:05 PM ET

All insider trades for GRCE

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named GRCE, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about GRCE.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about GRCE.

nakagai

Signals on GRCE come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the GRCE board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Grace Therapeutics, Inc. (GRCE): SEC filings, financials and insider trades · Nakagai